approval · primary record
EPINEPHRINE
FDA · NDA · 2026-06-22
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-06-22 |
| Brand | ADRENALIN |
| Sponsor | PH HEALTH |
| Route | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:09.313Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:EPINEPHRINE:2026-06-22
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.